60 Degrees Pharma withdraws mid-stage study application for COVID drug

France Nouvelles Nouvelles

60 Degrees Pharma withdraws mid-stage study application for COVID drug
France Dernières Nouvelles,France Actualités
  • 📰 SaltWire Network
  • ⏱ Reading Time:
  • 24 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 63%

(Reuters) - 60 Degrees Pharmaceuticals said on Monday it has withdrawn an application to the U.S. Food and Drug Administration (FDA) for a mid-stage ...

- 60 Degrees Pharmaceuticals said on Monday it has withdrawn an application to the U.S. Food and Drug Administration for a mid-stage study testing its experimental drug in COVID-19 - 60 Degrees Pharmaceuticals said on Monday it has withdrawn an application to the U.S. Food and Drug Administration for a mid-stage study testing its experimental drug in COVID-19 patients.

The decision follows FDA's comments regarding the study design, the company said, adding that it plans to resubmit a revised application later in the year after a feasibility assessment. The drug candidate, tafenoquine, was being developed to treat COVID-19 patients with mild-to-moderate symptoms and low risk of disease progression.The company said it will decide whether to continue self-funding the study or seek a partner to continue development.

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

SaltWire Network /  🏆 45. in CA

France Dernières Nouvelles, France Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

60 Degrees Pharma withdraws mid-stage study application for COVID drug60 Degrees Pharma withdraws mid-stage study application for COVID drug(Reuters) - 60 Degrees Pharmaceuticals said on Monday it has withdrawn an application to the U.S. Food and Drug Administration (FDA) for a mid-stage ...
Lire la suite »

India's Torrent Pharma in talks with CVC, Bain Capital for Cipla bid- sourcesIndia's Torrent Pharma in talks with CVC, Bain Capital for Cipla bid- sourcesBy Aditya Kalra and M. Sriram DELHI/MUMBAI (Reuters) - India's Torrent Pharmaceuticals is in talks with private equity funds CVC Capital Partners and ...
Lire la suite »

Exclusive-Novo Nordisk hires private U.S. firm to handle some Wegovy pen assembly -sourceExclusive-Novo Nordisk hires private U.S. firm to handle some Wegovy pen assembly -sourceBy Maggie Fick LONDON (Reuters) - Novo Nordisk has hired U.S. private contract manufacturer PCI Pharma Services to handle assembly and packaging of ...
Lire la suite »

BBC is 'urgently looking' into issues raised by Brand reportBBC is 'urgently looking' into issues raised by Brand reportLONDON (Reuters) - Britain's BBC said on Sunday it was
Lire la suite »

BBC is 'urgently looking' into issues raised by Brand reportBBC is 'urgently looking' into issues raised by Brand reportLONDON (Reuters) - Britain's BBC said on Sunday it was
Lire la suite »

Climate protesters in New York and across the globe send message to United NationsClimate protesters in New York and across the globe send message to United Nations(Reuters) - Thousands of protesters kicked off
Lire la suite »



Render Time: 2025-03-10 08:31:38